Biomea Fusion, Inc.
NASDAQ:BMEABiotechnology
-$0.03 today
- Market cap
- $53.18M
- Beta
- -0.33
- P/E (TTM)
- -1.9
- EPS (TTM)
- -$0.62
Volume 3.50M
Average 1.52M
BMEA Net Income
Bottom-line profit after all expenses, interest, and taxes.
Biomea Fusion, Inc.NASDAQ: BMEA
Net Income · Q1 FY2026 · quarter ended Mar 2026
Net income remains negative
Q1 FY2026 net income was -$12.42M, compared with -$29.26M a year earlier. Trailing-twelve-month net income was -$44.95M.
Context
- Net income grew in size in 2 of the last 3 fiscal years.
- FY2025 was the smallest annual figure in the 4 fiscal years shown.
What to watch
Whether net income reaches the consensus estimate from 6 analysts of -$49.78M (+19.4%) for the fiscal year ending Dec 2026, a slowdown from the +55.4% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -$12.42M-369.2% QoQ
- Last fiscal yearDec 2025
- -$61.8M+55.4% YoY
- LTMMar 2026
- -$44.95M+65.1% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +57.6% | +22.1% | -35.5 pp |
| 1 year | +55.4% | +19.4% | -35.9 pp |
| 3-year CAGR | — | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Income history
USD · from the income statement
- Latest · FY2025
- (61.8M) USD
- Year-over-year change
- +55.4%
| Period | Period end | Net Income | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (61.8M) | +55.4% |
| FY2024 | 2024-12-31 | (138.43M) | -18.1% |
| FY2023 | 2023-12-31 | (117.26M) | -43.3% |
| FY2022 | 2022-12-31 | (81.83M) | -96.9% |
| FY2021 | 2021-12-31 | (41.57M) | — |
Net Income vs competitors
How BMEA compares with its peers on the latest reported figures
- BMEA's LTM Mar 2026 net income of -$44.95M is the 2nd highest of the 9 companies compared; the peer median is -$95.14M.
- Its year-over-year change of +65.1% is the highest of 9, against a peer median of -14.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | -$39.95M | -162.9% | — | — | |
| LTM Mar 2026 | -$44.95M | +65.1% | — | — | |
| LTM Mar 2026 | -$78.34M | -28.7% | — | — | |
| LTM Mar 2026 | -$86.3M | -66.7% | — | 2193.7% | |
| LTM Mar 2026 | -$88.87M | +31.7% | — | — | |
CBUSCibus, Inc. | LTM Mar 2026 | -$101.42M | +63.1% | — | 2366.3% |
| LTM Mar 2026 | -$104.29M | -8.2% | — | — | |
| LTM Mar 2026 | -$108M | -21.2% | — | — | |
| LTM Mar 2026 | -$153.6M | +37.4% | — | 154.2% | |
| Peer median (excluding BMEA) | -$95.14M | -14.7% | — | 2193.7% | |
Competitors are the stored peer set for BMEA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 0 | 0 | 0 | 0 | 1.41M |
| Gross Profit | 0 | 0 | 0 | 0 | (1.41M) |
| Gross Margin | — | — | — | — | — |
| Research & Development | 28M | 62.71M | 102.55M | 118.09M | 61.98M |
| Selling, General & Admin | 13.67M | 20.92M | 23.59M | 25.99M | 19.33M |
| Operating Expenses | 41.67M | 83.63M | 126.14M | 144.07M | 79.9M |
| Depreciation & Amortization | 249K | 691K | 1.52M | 1.75M | 1.41M |
| EBITDA | (41.32M) | (81.14M) | (115.74M) | (136.68M) | (60.39M) |
| EBITDA Margin | — | — | — | — | — |
| Operating Income | (41.67M) | (83.63M) | (126.14M) | (144.07M) | (81.31M) |
| Operating Margin | — | — | — | — | — |
| Interest Income | 100K | 1.81M | 8.88M | 5.64M | 1.86M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 100K | 1.81M | 8.88M | 5.64M | 19.51M |
| Income Before Tax | (41.57M) | (81.83M) | (117.26M) | (138.43M) | (61.8M) |
| Pre-Tax Margin | — | — | — | — | — |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | (41.57M) | (81.83M) | (117.26M) | (138.43M) | (61.8M) |
| Net Margin | — | — | — | — | — |
| EPS (Basic) | (1.74) | (2.80) | (3.44) | (3.83) | (1.18) |
| EPS (Diluted) | (1.74) | (2.80) | (3.44) | (3.83) | (1.18) |
| Weighted Avg Shares | 23.86M | 29.27M | 34.11M | 36.11M | 52.23M |
| Weighted Avg Shares (Diluted) | 23.86M | 29.27M | 34.11M | 36.11M | 52.23M |
Biomea Fusion, Inc.
NASDAQ:BMEA
Intrinsic Alpha fair value
Locked
Current Price
$0.74
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.